Abstract
Viral hepatitis is the commonest cause offulminant hepatic failure (FHF) in developing countries.We evaluated the early indicators of prognosis in thesepatients by multivariate analysis. The records of 204 consecutive patients with acute liverfailure admitted with hepatic encephalopathy over fiveyears were studied. The etiology of these patientsincluded virus related in 186 (91.1%), drug induced in 15 (7.4%), Wilson's disease in one (0.5%),acute Budd-Chiari syndrome in one (0.5%), and malignantinfiltration in one (0.5%). Patients with FHFcomplicating viral hepatitis were analyzed by univariate and multivariate analysis. These patients werefurther subclassified depending upon the intervalbetween the onset of jaundice and the onset ofencephalopathy into hyperacute (HALF; interval 0-7days), acute (ALF; interval 8-28 days) and subacuteliver failure (SALF; interval 4-12 weeks). Sixty (32.3%)patients with viral hepatitis survived. Univariateanalysis showed that the interval between onset of encephalopathy and onset of jaundice, grade ofencephalopathy, raised intracranial pressure,prothrombin time, and serum bilirubin levels onadmission were related to outcome in these patients.Multivariate logistic regression analysis showed that thepresence of raised intracranial pressure at the time ofadmission, prothrombin time >100 sec on admission,age (>50 yr), and onset of encephalopathy seven days after onset of jaundice were associated withpoor prognosis. Forty seven (37.0%) of 129 patients withHALF survived compared with 9 (22.5%) of 40 with ALF and4 (21.1%) of 19 with SALF (P = NS). Raised intracranial pressure was more frequent in patients withHALF (48.8%) than in patients with ALF (32.5%) and SALF(15.8%; P = 0.01), while clinically detectable asciteswas more frequent in patients with SALF (78.9%) compared with HALF (19.7%) and ALF (37.5%; P< 0.0001). The factors adversely affecting theoutcome in our patients with FHF complicating viralhepatitis include presence of overt clinical features of raised ICP at the time of hospitalization,prothrombin time (>100 sec) on admission, age (>50yr), and onset of encephalopathy seven days after onsetof jaundice.
Similar content being viewed by others
REFERENCES
Trey C, Davidson LS: The management of fulminant hepatic failure. InH Popper, F Shaffer (eds). Progress in Liver Disease. New York, Grune and Startton, 1970, pp 282-298
Bernuau J, Rueff B, Behamou J-P: Fulminant and subfulminant liver failure: Definitions and causes. Semin Liver Dis 6:97-106, 1986
O'Grady JG, Alexander GJM, Hayllar KM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439-445, 1989
O'Grady JG, Schalm SW, Williams R: Acute liver failure: Redifining the syndromes. Lancet 342:273-275, 1993
Bernuau J, Benhamou J-P: Classifying acute liver failure. Lancet 342:252-253, 1993
Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, Degott C, Bezeaud A, Rueff B, Benhamou J-P: Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6:648-651, 1986
O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R: Controlled trils of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94:1186-1193, 1983
Pauwels A, Mostefa-Kara N, Florent C, Levy VG: Emergency liver transplantation for acute liver failure: Evaluation of London and Clichy criteria. J Hepatol 17:124-127, 1993
Anand AC, Nightingale P, Neuberger JM: Early indicators of prognosis in fulminant hepatic failure: An assessment of King's criteria. J Hepatol 26:62-68, 1997
Gimson AES, Braude S, Mellon PJ, Gimson AES, Braude S. Mellon PJ, Canalese J, Williams R: Earlier charcoal hemoperfusion in fulminant hepatic failure. Lancet 2:681-683, 1982
Ede RJ, Gimson AES, Bihari D, Ede RJ, Gimson AES, Bihari D, Williams R: Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 2:43-51, 1986
Christensen R: Log-Linear Models. New York, Springer-Verlag, 1990, pp 255-269
Nanda SK, Yalcinkaya K, Panigrahi AK, Acharya SK, Jameel S, Panda SK: Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol 42:133-137, 1994
Tandon BN, Joshi YK, Tandon M: Acute liver failure; experience with 145 patients. J Clin Gastroenterol 8:664-668, 1986
Dilawari JB, Kartar Singh, Chawla YK, Ramesh GN, Chauhan A, Bushnurmath SR, Sharma TR, Sokhey CS: Hepatitis E virus: Epidemiological, clinical and serological studies of a North Indian epidemic. India J Gastroenterol 13:44-48, 1994
Khuroo MS, Deurmeyer W, Zergar SA, Aharger MA, Shah MA: Acute sporadic non-A non-B hepatitis in India. Am J Epidemiol 118:360-364, 1983
Takahashi Y, Shimzu M: Aetiology and prognosis of fulminant viral hepatitis in Japan: A multivariate study. J Gastroenterol Hepatol 6:159-164, 1991
Acharya SK, Dasarathy S, Tandon BN: Should we redefine acute liver failure? Lancet 342:1421-1422, 1993 ( letter)
Hoofnagle JH, Carithers RL, Shapiro C, Ascher N: Fulminant hepatic failure: Survey of a workshop. Hepatology 21:240-252, 1995
Trey C: The fulminant hepatic failure surveillance study: Brief review of the effects of presumed aetiology and age on survival. CMAJ 106:525-526, 1972
Acharya SK, Dasarathy S, Kumar TL, Sushma S, Prasanna KSU, Tandon A, Sreenivas V, Nijhavan S. Panda SK, Nanda SK, Irshad M, Joshi YK, Dattagupta S, Tandon RK, Tandon BK: Culminant hepatitis in a tropical population: Clinical course, cause and early predictors of outcome. Hepatology 23:1448-1455, 1996
Lebrec D, Novel O, Bernuau J, Rueff B, Benhamou JP: Portal hypertension in fulminant viral hepatitis. Gut 21:962-964, 1980
Novasa M, Garcia-Pagon J-C, Bosch J, Riera JR, Bariares R, Mas A, Bruguera M: Portal hypertension in acute liver failure. Gut 33:965-968, 1992
Chu CM, Chiu KW, Liaw YF: The prevalence and prognostic significance of spontaneous bacterial peritonitis in severe acute hepatitis with ascitis. Hepatology 15:799-803, 1992
Rights and permissions
About this article
Cite this article
Dhiman, R.K., Seth, A.K., Jain, S. et al. Prognostic Evaluation of Early Indicators in Fulminant Hepatic Failure by Multivariate Analysis. Dig Dis Sci 43, 1311–1316 (1998). https://doi.org/10.1023/A:1018876328561
Issue Date:
DOI: https://doi.org/10.1023/A:1018876328561